Greece Struggles to...
Health Care: Drugs
Genzyme Corporation (GENZ: NASDAQ)
$76.25 -0.08 | -0.10%
04/08/11 - 04:00 PM ET
5.85M / 6.37M
Vol / Avg. Vol:76.33 / 76.33
Open / Prev. Close:76.24 - 76.38
Today's Range:45.39 - 76.48
52 Wk Range:7.09%
Performance YTD:TheStreet Rating:
Portfolios with GENZ
- Portfolio NameUser Type
- ProRichard Perry - Perry Capital
- Contributor10 Stocks Hedge Funds Are B...
- Contributor10 Top Hedge Fund Stock Buys
- ProShumway Capital Partners
- Contributor10 S&P 500 Companies With T...
- Contributor10 Stocks Favored by Hedge ...
- Contributor10 Top Hedge Fund Buys
- ContributorNew Guru Stock Positions 11...
- ProLegg Mason Value C (LMVTX)
- Contributor21 S&P 500 Stocks Up More T...
Latest GENZ Headlines from TheStreet
- 10 Cities Unaffected by a Bad Economy 05.09.11 | 08:05 am
- BlackRock Trades Heavy on Index Inclusion 04.01.11 | 05:04 pm
- 10 Stocks to Watch: Align, Apollo 03.30.11 | 04:03 pm
- Genzyme Stock Hits New 52-Week High (GENZ) 03.30.11 | 10:03 am
- Telecoms Push Stocks Higher After Payroll Report 03.30.11 | 08:03 am
- 10 Stocks Hedge Funds Are Buying Like Crazy 03.08.11 | 10:03 am
- Genzyme Stock Hits New 52-Week High (GENZ) 03.03.11 | 02:03 pm
- 10 Popular Drugs Set to Lose Their Patents 03.03.11 | 09:03 am
- 10 Top Hedge Fund Stock Buys 02.25.11 | 12:02 pm
- 3 Stocks I Saw on TV
02.23.11 | 08:02 am
Press Releases for GENZ
- Sanofi-aventis Successfully Completes Exchange Offer For Genzyme Corporation - PR Newswire 04.04.11 | 12:04 am
- Genzyme Board Unanimously Recommends That Shareholders Accept Sanofi-aventis Revised Offer And Tender Shares - Business Wire 03.07.11 | 08:03 am
- Genzyme Completes Sale Of Pharmaceuticals Business To International Chemical Investors Group - Business Wire 03.01.11 | 09:03 am
- Genzyme Recognizes International Rare Disease Day By Launching New Patient Advocacy Grant Program - Business Wire 02.28.11 | 07:02 am
- Three-Year Data From Phase 2 Trial Of Genzyme Gaucher Disease Oral Compound Suggest Sustained Or Further Improvement Across All Endpoints - Business Wire 02.18.11 | 01:02 pm
- Genzyme Reports Financial Results For Fourth Quarter Of 2010 And Full Year - Business Wire 02.16.11 | 07:02 am
- Genzyme Completes Sale Of Diagnostics Business To Sekisui Chemical Co. - Business Wire 02.01.11 | 08:02 am
- Genzyme Will Allow Sanofi-Aventis To Conduct Due Diligence - Business Wire 01.31.11 | 08:01 am
- Genzyme To Build Additional Plant To Support Growth Of Myozyme® And Lumizyme® - Business Wire 01.20.11 | 07:01 am
- Genzyme Financial Recovery Continues In Fourth Quarter - Business Wire 01.11.11 | 12:01 pm
Partner Headlines for GENZ
- Sanofi targets 5% boost in sales annually - Financial Times 09.06.11 | 08:09 pm
- Insurer offers protection to pharma groups - Financial Times 07.24.11 | 03:07 pm
- Hedge Funds' Favorite Stock Picks - Seeking Alpha 05.02.11 | 08:05 am
- Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11) - Seeking Alpha 04.10.11 | 04:04 am
- Is Celgene the Perfect Stock? - AOL 04.06.11 | 06:04 pm
- John Paulson Is Bullish on These 5 Stocks - Seeking Alpha 04.04.11 | 08:04 am
- Valeant's Cephalon bid portends new era - Financial Times 04.04.11 | 01:04 am
- 11 'Coiled Spring' Breakout Candidates Potentially Poised to Pop - Seeking Alpha 04.03.11 | 08:04 am
- Company News for March 31, 2011 - Corporate Summary - Zacks 03.31.11 | 10:03 am
- Carl Icahn's Favorite Stocks - Seeking Alpha 03.31.11 | 09:03 am
